Natalie S Callander (Natalie Callander)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 12

Top Topics

Oxide Nanoparticles

Acute Lymphoblastic Leukemia

Top Venues

Blood cancer journal

Molecular cancer research : MCR

Research square

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

David J Chung, Nina Shah, Juan Wu, Brent R Logan, Lina Bisharat, Natalie S Callander, Giulia Cheloni, Kenneth C Anderson, Thinle Chodon, Binod Dhakal, Steven M Devine, Poorvi Somaiya Dutt, Yvonne A Efebera, Nancy L Geller, Haider Ghiasuddin, Peiman Hematti, Leona Holmberg, Alan Howard, Bryon Johnson, Dimitra Karagkouni, Hillard M Lazarus, Ehsan Malek, Philip L McCarthy, David H McKenna, Adam Mendizabal, Ajay K Nooka, Nikhil C Munshi, Lynn O'Donnell, Aaron P Rapoport, Jane Reese, Jacalyn Rosenblatt, Robert J Soiffer, Dina Stroopinsky, Lynne Uhl, Ioannis S Vlachos, Edmund K Waller, James W Young, Marcelo C Pasquini, David Avigan
Randomized Trial of a Personalized Dendritic Cell Vaccine after Autologous Stem Cell Transplant for Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ehsan Malek, Jeries Kort, Leland Metheny, Pingfu Fu, Parameswaran N Hari, Gen Li, Yvonne A Efebera, Natalie S Callander, Muzaffar H Qazilbash, Sergio A Giralt, Amrita Krishnan, Edward Stadtmauer, Hillard Lazarus
Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial. Research square (2023)
Hae Yeun Chang, Mailee Huynh, Avtar Singh Roopra, Natalie S Callander, Shigeki Miyamoto
HAPLN1 matrikine: A bone marrow homing factor linked to poor MM patient outcomes. Blood advances (2023)
Nicholas J Hess, David P Turicek, Jeremiah Riendeau, Sean J McIlwain, Emmanuel Contreras Guzman, Kalyan Nadiminti, Amy W Hudson, Natalie S Callander, Melissa C Skala, Jenny E Gumperz, Peiman Hematti, Christian M Capitini
Inflammatory CD4/CD8 double-positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology. Science advances 9 (12) (2023)
Shaji K Kumar, Lawrence Baizer, Natalie S Callander, Sergio A Giralt, Jens Hillengass, Boris Freidlin, Antje Hoering, Paul Gerard Richardson, Elena I Schwartz, Anthony Reiman, Suzanne Lentzch, Philip L McCarthy, Sundar Jagannath, Andrew J Yee, Richard F Little, Noopur S Raje
Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee. Blood cancer journal 12 (6) (2022)
Christina Mark, Jay Warrick, Natalie S Callander, Peiman Hematti, Shigeki Miyamoto
A Hyaluronan and Proteoglycan Link Protein 1 Matrikine: Role of Matrix Metalloproteinase 2 in Multiple Myeloma NF-κB Activation and Drug Resistance. Molecular cancer research : MCR 20 (9) (2022)
Jarrod Longcor, Natalie S Callander, Kate Oliver, Asher Chanan-Khan, Sikander Ailawadhi
Iopofosine I-131 treatment in late-line patients with relapsed/refractory multiple myeloma post anti-BCMA immunotherapy. Blood cancer journal 12 (9) (2022)
Susan Bal, Ehsan Malek, Ankit Kansagra, Saad Z Usmani, Ravi Vij, Kelly N Godby, Robert F Cornell, Yubin Kang, Elvira Umyarova, Smith Giri, Saurabh Chhabra, Michaela Liedtke, Natalie S Callander, Parameswaran N Hari, Shaji K Kumar, Luciano J Costa
Treatment outcomes of triple class refractory multiple myeloma: a benchmark for new therapies. Leukemia (2021)
Luciano José Megale Costa, Saurabh Chhabra, Eva Medvedova, Bhagirathbhai R Dholaria, Timothy Martin Schmidt, Kelly N Godby, Rebecca W Silbermann, Binod Dhakal, Susan Bal, Smith Giri, Anita D Souza, Aric Hall, Pamela Hardwick, James Omel, Robert Frank Cornell, Parameswaran N Hari, Natalie S Callander
Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (25) (2021)
Sagar Lonial, Ajay K Nooka, Praneetha Thulasi, Ashraf Z Badros, Bennie H Jeng, Natalie S Callander, Heather A Potter, Douglas Sborov, Brian E Zaugg, Rakesh Popat, Simona Degli Esposti, Julie Byrne, Joanna Opalinska, January Baron, Trisha Piontek, Ira Gupta, Reza Dana, Asim V Farooq, Kathryn Colby, Andrzej J Jakubowiak
Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM). Blood cancer journal 11 (5) (2021)
Timothy Martin Schmidt, Natalie S Callander
Progress in the Management of Smoldering Multiple Myeloma. Current hematologic malignancy reports 16 (2) (2021)
Jorge J Castillo, Natalie S Callander, Muhamed Baljevic, Douglas W Sborov, Shaji K Kumar
The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance. American journal of hematology 96 (7) (2021)